Evidence map›Paper›PMID 32095400›Full record

ArticlePlastic and reconstructive surgery. Global open2020

Recommendations for the Use of Antibiotics in Primary and Secondary Esthetic Breast Surgery.

Lukas Prantl, Arash Momeni, Vanessa Brebant, Britta Kuehlmann, Norbert Heine, Niklas Biermann, Eva Brix

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lukas PrantlUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Arash MomeniDivision of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, Calif.
Vanessa BrebantUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Britta KuehlmannUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Norbert HeineUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Niklas BiermannUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.
Eva BrixUniversity Center of Plastic, Hand- and Reconstructive Surgery, University Hospital Regensburg, Regensburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of systemic prophylactic antibiotics to reduce surgical-site infection in esthetic breast surgery remains controversial, although the majority of surgeons prefer to utilize antibiotics to prevent infection. Nonetheless, postoperative acute and subclinical infection and capsular fibrosis are among the most common complications following implant-based breast reconstruction. After esthetic breast augmentation, up to 2.9% of women develop infection, with an incidence rate of 1.7% for acute infections and 0.8% for late infections. After postmastectomy reconstruction (secondary reconstruction), the rates are even higher. The microorganisms seen in acute infections are Gram-positive, whereas subclinical late infections involving microorganisms are typically Gram-negative and from normal skin flora with low virulence. In primary implantation, a weight-based dosing of cefazolin is adequate, an extra duration of antibiotic cover does not provide further reduction in superficial or periprosthetic infections. Clindamycin and vancomycin are recommended alternative for patients with

Identifiers

PMID32095400
PMCPMC7015596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.